Background: Cardiovascular disease (CVD) is the leading cause of death in patients with chronic obstructive pulmonary disease (COPD) and such patients tend to carry a heavy burden of risk factors for CVD. There is little information on the documentation and management of CVD risk factors in COPD patients. Aim: To audit the recording and management of CVD risk factors in 200 COPD patients attending the respiratory out-patient clinics at two University teaching hospitals. Design: Retrospective analysis of hospital records. Results: While there was reasonable recording of a history of CVD risk factors such as hypertension and hyperlipidaemia, the actual recording of risk factor levels was poor-blood pressure and heart rate were recorded in less than half of subjects; lipids, waist circumference, HbA1c and height were essentially not recorded at all. Conclusions: Best practice guidelines and standard operating procedures for CVD risk factor recording and control require to be developed if the major cause of death in COPD subjects, CVD, is to be addressed. An outline for a standard operating procedure is presented in the Appendix. Serial audits will be required to assess the efficacy of such measures.
Introduction
Patients with chronic obstructive respiratory disease (COPD) carry a heavy burden of risk factors for cardiovascular disease (CVD) 1 and the coexistence of both conditions has an important impact on clinical outcomes. 2 CVD is the leading cause of death in such subjects. 3 In addition to the high prevalence of CVD risk factors in patients with COPD, recent studies have shown that CVD is more frequent in COPD independent of these shared risk factors. 4 In view of these observations, meticulous recording and management of cardiovascular risk factors should form a critical part of the overall management of patients with COPD. We were unable to identify any systematic audit of the recording and management of CVD risk factors in patients with COPD. We therefore adapted a simple and effective international audit tool SUrvey of Risk Factors (SURF) that we developed to study the risk factor recording and control in subjects with coronary heart disease (CHD) 5, 6 to examine these issues in patients with COPD.
The advice of the local ethics committee was sought. It ruled that, since the only data being recorded were those readily available in the patient record, and since no intervention was involved, it was not necessary to submit the study for ethical approval.
Objectives
The aims of this audit were to:
• Document the extent to which CVD risk factors are recorded in the medical notes of subjects attending respiratory outpatient services in two University teaching hospitals. • Ascertain if possible if recorded risk factors were at the target levels defined by the current Joint European Guidelines on the prevention of CVD in clinical practice. 7 • Explore whether this audit might form the basis for national or international guidance with regards to CVD risk factor recording and control in subjects with COPD.
Materials and methods

Study population
The audit was based on a retrospective chart review of patients with a clinical diagnosis of COPD attending respiratory outpatient clinics in two University hospitals in Dublin: Tallaght Hospital and St. Vincent's University Hospital. New and review patients of both genders were only included if they had attended the respiratory clinic within the last 1 year. All patients included had a documented diagnosis of COPD.
Patients were aged 18 years or over. There was no upper age limit.
Data collection
SURF is an international system for of auditing the recording and control of cardiovascular risk factors in subjects with CHD. The pilot study and phase I 5, 6 have confirmed that it is easy to use, taking less than 2 min per patient to complete. The one-page data collection sheet was adapted for use in patients with COPD. Information recorded is detailed in Table 1 .
Hospital number and patient initials were recorded to exclude duplicate entries and were removed before transfer of data to an excel spreadsheet in order to protect confidentiality. Results were analysed using the excel program.
Results
Data on 200 patients (107 men and 93 women) aged between 43 and 88-year-old were collected from two teaching hospitals, Tallaght hospital and St. Vincent's University hospital (SVUH). Each hospital contributed data on 100 individuals. Table 2 shows baseline characteristics for the participants in both hospitals. The percentage of men and women was nearly the same in the centres. Pulmonary function test (PFT) results were not recorded in 16.5% of patients and treatment of COPD was not recorded in 14.5%.
Demographics
Cardiovascular risk factors
The prevalence of current smoking was nearly the same in both centres: in Tallaght hospital (26%) and in SVUH (23%). There was no record of smoking status in 13% in both hospitals (11% of subjects in Tallaght and 15% in SVUH). Among ex-smokers, pack-years were not recorded in 17.5% (Table 3) .
A medical history of cardiovascular risk factors was recorded in 88 patients (44%) in both centres (Table 3 ) with a prevalence of hypertension of 37%, dyslipidaemia 31% and diabetes 11%.
Among 66 (33%) patients with a recorded history of established CVD, 29.5% had CHD, 6.5% stroke/transient ischemic attack (TIA) and 4% peripheral vascular disease (PVD). Twentynine (14.5%) patients had undergone previous coronary interventions although four of these were not recorded as having known CVD. Medical treatment for CVD was recorded in 32 (16%) of patients who had no record of known CVD.
Overall, the recording of risk factor measurements was very poor (Table 4 ). Blood pressure and heart rate were recorded in less than half of subjects and lipids, waist circumference and HbA1c and height were essentially not recorded at all.
Recording of blood pressure (BP) and heart rate was appreciably better in Tallaght (58% and 47%, respectively) than in SVUH (24% and 18%, respectively) .
Because of the poor recording of risk factors, it was not possible to comment on their control except for BP. In the 82 (41%) in whom it was recorded, 18 (22%) were above the usually recommended maximum level of 140/90.
Discussion
We report the first audit of CVD risk factor recording in subjects with established COPD attending respiratory clinics. This study has confirmed that data can be collected as easily and quickly as in the SURF CHD audit. 5, 6 The collection sheet used in this audit was modified for use in respiratory patients. A history of CVD risk factors such as hypertension, dyslipidaemia or/and diabetes was recorded in 44% (88 patients). This is most likely due to the traditional model of medical history taking. However, the treatment of risk factors in these patients was not recorded in 26%. Known CVD was documented in nearly one-third, but this information was missing in 36 (18%).
Documentation of risk factors measurements was very poor apart from BP, heart rate and weight. The better recording of BP and height in Tallaght hospital was most likely due to standardized nursing practices.
Only 10% of COPD patients had documented evidence of the use of guideline-recommended advice on smoking cessation; even then details of the exact advice given were not recorded in any case.
There is a strong association between COPD and increased risk of CVD; a large UK-based study on 30 000 patients with COPD reported that these patients are nearly five times more likely to have CVD than those without COPD. 8 Other studies show higher rate of hospitalization resulting from cardiovascular causes independent of pre-existing CVD risk factors. 9 It is also important to record the results of PFT. Multiple cohort and epidemiological studies have shown a direct relationship between a low forced expiratory volume in the first second (FEV1) and CVD mortality. 4 Our audit demonstrates that PFT results
were not recorded in 16.5% of patients. The careful evaluation, documentation and monitoring for CVD risk factors are clearly warranted in COPD individuals to reduce the burden of superimposed atherosclerosis and reduce the risk of future cardiovascular events.
We conclude that, although a history of cardiovascular risk factors is reasonably well recorded in COPD patients, the actual documentation of risk factor levels, whether or not or how they are being managed and the proportion of patients known to be at target is dismal.
Our purpose is not to criticize but to prompt debate and the establishment of best practice guidelines and standard operating procedures (see Appendix) for respiratory clinics with regards to CVD risk factor recording, documentation and control. It is planned to prepare such documentation for wider discussion in the hope that this may contribute to the development of national and perhaps international guidance. SURF COPD is sufficiently simple as to allow completion of the audit cycle by means of further audits after the implementation of the above service improvement measures.
The next phase of SURF COPD would be prospective collection of data on risk factors and their management. Collection of the information at the time of outpatient review has the added advantage of prompting a discussion of these risks and thereby has the potential to improve management while concurrently auditing the documentation of CVD risk factors. b. A check list should be included in the patient record to document the recording of these factors. c. A flowchart should be used to document the serial recording of smoking, lipids, BP, blood glucose, heart rate and body weight at at least 6 monthly intervals. This chart should also note current European Society of Cardiology major risk factor targets for high risk subjects-no tobacco, BP<140/90, LDL cholesterol <1.8mmol/l). d. The flowchart should include columns to record if advice about smoking has been given and the use and dose of anti-hypertensive and lipid lowering drugs. e. An audit of the recording and control of risk factors should be undertaken at 2 yearl intervals together with a written process improvement plan.
